Avalyn Pharma AVLN 深 滬
已收盤 05-08 16:00:00 美东时间
27.33
+0.400
+1.49%
華盛通- 最 高29.00
- 今 開26.66
- 成交量 29.04万股
- 最 低 26.64
- 昨 收 26.93
- 總市值 11.43亿
- 52周最高 30.6683
- 市盈率 靜 --
- 換手率 0.69%
- 52周最低 25.05
- 委 比 92.02%
- 總股本 4181.20万
- 歷史最高 30.6683
- 量 比 0.49
- 振 幅 8.76%
- 歷史最低 25.05
- 每 手 1
- 風險率 3.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | 净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%
累计净回报超2600%！资管公司潘兴广场上市三日累涨超58%；慧荣科技周涨超52%，Q1营收同比翻倍大超预期>>
05-04 18:33
Lung disease drug developer Avalyn surges on public debut
Avalyn Pharma (AVLN), a biotech focused on developing inhaled therapeutics for the lung disorder pulmonary fibrosis, climbed ~55% on Thursday following an upsized initial public offering that raised t...
05-01 01:27
Avalyn Announces Pricing of Upsized Initial Public Offering
Avalyn Pharma Inc. announced the pricing of its upsized initial public offering of 16,666,667 shares at $18.00 per share, expecting to raise $300 million. The shares will begin trading on the Nasdaq Global Select Market on April 30, 2026, under the ticker "AVLN," with the offering closing on May 1, 2026. The company, focused on inhaled therapies for rare respiratory diseases, has granted underwriters a 30-day option to purchase an additional 2.5 ...
04-30 01:00
